2-(Arylamino)aryliminophosphoranes as Easily Available and Convenient Starting Materials in the Synthesis of 1,2,3-Benzotriazoles

Emilia Łukasik; Zbigniew Wróbel

doi:10.1055/s-0034-1378448

Synlett, Table of Contents

Synlett 2014; 25(14): 1987-1990
DOI: 10.1055/s-0034-1378448

letter

2-(Arylamino)aryliminophosphoranes as Easily Available and Convenient Starting Materials in the Synthesis of 1,2,3-Benzotriazoles

Emilia Łukasik

Institute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44, 01-224 Warsaw 42, Poland Fax: +48(22)6326681 Email: zbigniew.wrobel@icho.edu.pl

,

Zbigniew Wróbel*

Institute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44, 01-224 Warsaw 42, Poland Fax: +48(22)6326681 Email: zbigniew.wrobel@icho.edu.pl

› Author Affiliations

Abstract

All articles of this category

Abstract

1-Aryl-1,2,3-benzotriazole systems are synthesized in the high-yielding cyclocondensation of 2-(arylamino)aryliminophosphoranes under mild conditions. The reaction concludes the three-step, halogen-free synthetic route starting from simple nitroarenes and arylamines.

Key words

cyclization - condensation - heterocycles - annulation - ylides

Full Text

References

References and Notes

1a Sudhir MS. A, Nadh RV, Radhika S. Drug Invent. Today 2013; 5: 126

2 Li X, Fu J, Shi W, Luo Y, Zhang X, Zhu H, Yu H. Bull. Korean Chem. Soc. 2013; 34: 2387
3 Boido A, Boido CC, Sparatore F. Farmaco 2001; 56: 263
4 Kale RR, Prasad V, Mohapatra PP, Tiwari VK. Monatsh. Chem. 2010; 141: 1159
5 Piccionello AP, Guarcello A. Curr. Bioact. Compd. 2010; 6: 266

6a Znoiko SA, Kambolova AS, Maizlish VE, Shaposhnikov GP, Abramov IG, Filimonov SI. Russ. J. Gen. Chem. 2009; 79: 1735
6b Nolan KA, Humphries MP, Barnes J, Doncaster JR, Caraher MC, Tirelli N, Bryce RA, Whitehead RC, Stratford IJ. Bioorg. Med. Chem. 2010; 18: 696
6c Fujiwara C, Hagaya M, Kakuta H, Kawata K, Nakayama M, Ohsawa F, Ohta Y, Shinozaki R, Yakushiji N, Yamada Sh, Makishima M, Uno Sh, Tai A, Maehara A, Nakayama M, Oohashi T, Yasui H, Yoshikawa Y. ACS Med. Chem. Lett. 2012; 3: 427
6d Barnes J, Bryce RA, Caraher MC, Doncaster JR, Humphries MP, Nolan KA, Stratford IJ, Tirelli N, Barnes J, Doncaster JR, Whitehead RC. Bioorg. Med. Chem. 2010; 18: 696
6e Kulagowski JJ, Moody CJ, Rees CW. J. Chem. Soc., Perkin Trans. 1 1985; 2733

7a Beletskaya IP, Davydov DV, Moreno-Mañas M. Tetrahedron Lett. 1998; 39: 5617
7b Mukhopadhyay C, Tapaswi PK. Synth. Commun. 2012; 42: 2217
7c Antilla JC, Barder TE, Baskin JM, Buchwald SL. J. Org. Chem. 2004; 69: 5578
7d Alakonda L, Periasamy M. Synthesis 2012; 44: 1063
7e Jena AK, Mohapatra S, Panda N, Rout SR. Tetrahedron Lett. 2011; 52: 1924

8a Cao W, Chen J, Chen Y, Lin Y, Ma X, Xu D. Tetrahedron 2011; 67: 856
8b Chen Y.-L, Sun J.-Q, Wei X, Wong W.-Y, Lee AW. M. J. Org. Chem. 2004; 69: 7190

9a Song T, Xu L, Zhao J, Zhao J, Zhu S. Tetrahedron 2011; 67: 910
9b Rosevear J, Wilshire JF. K. Aust. J. Chem. 1991; 44: 1097

10a Ankati H, Biehl E. Tetrahedron Lett. 2009; 50: 4677
10b Moses JE, Zhang F. Org. Lett. 2009; 11: 1587
10c Chen Y, Larock RC, Shi F, Waldo JP. Org. Lett. 2008; 10: 2409

11 Łukasik E, Wróbel Z. Synlett 2014; 25: 217

12a Wróbel Z, Kwast A. Synlett 2007; 1525
12b Wróbel Z, Kwast A. Synthesis 2010; 3865

13 Synthesis of 1-Aryl-1,2,3-benzotriazoles 2 – General Procedure Iminophosphorane 1 (1 mmol) was dissolved in AcOH (5 mL), cooled down to 0 °C, and NaNO₂ (1.1 mmol) was added portionwise with stirring. The reaction was stirred until completion (TLC control, usually 5–20 min). The mixture was poured into H₂O, extracted with EtOAc, dried with Na₂SO₄, and the solvent was evaporated. The crude product was purified by column chromatography.
14 Analytical Data for Representative Products Compound 2a: white solid; mp 152–154 °C. ¹H NMR (400 MHz, CDCl₃): δ = 1.92 (s, 6 H), 7.21 (d, J = 2.0 Hz, 1 H), 7.25 (s, 1 H), 7.27 (s, 1 H), 7.37–7.42 (m, 2 H), 8.08 (d, J = 8.8 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 17.5, 112.3, 118.3, 127.0, 129.1, 131.1, 132.9, 134.8, 136.3, 142.6, 145.2. MS (EI): m/z (%) = 259 (13), 257 (40), 228 (39), 216 (13), 214 (39), 194 (100), 193 (22). HRMS (EI): m/z calcd for C₁₄H₁₂N₃ ³⁵Cl: 257.0720; found: 257.0730. Compound 2b: pink crystals; mp 136–138 °C. ¹H NMR (500 MHz, CDCl₃):¹⁶ δ = 2.40 (s, 3 H), 7.30 (dd, J = 8.8, 1.8 Hz, 1 H), 7.33–7.36 (m, 2 H), 7.52–7.55 (m, 2 H), 7.65 (d, J = 1.8 Hz, 1 H), 7.98 (d, J = 8.8 Hz, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 21.2, 110.2, 121.1, 122.9, 125.5, 130.5, 133.0, 134.0, 134.6, 139.2, 150.0. MS (EI): m/z (%) = 245 (16), 243 (51), 216 (29), 215 (44), 214 (76), 180 (100), 179 (12). HRMS (EI): m/z calcd for C₁₃H₁₀N₃ ³⁵Cl: 243.0563; found: 243.0563. Compound 2c: white solid; mp 92–95 °C. ¹H NMR (400 MHz, DMSO-d ₆): δ = 1.84 (s, 6 H), 4.11 (s, 3 H), 6.94–7.01 (m, 2 H), 7.33–7.39 (m, 2 H), 7.45–7.51 (m, 1 H). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 16.9, 56.9, 101.5, 105.9, 128.8, 130.6, 133.3, 134.9, 135.4, 135.8, 135.9, 151.7. MS (EI): m/z (%) = 289 (51), 288 (29), 287 (100), 258 (24), 246 (37), 245 (23), 224 (78), 218 (16), 217 (10), 216 (51), 209 (39), 201 (21), 181 (52), 180 (39). HRMS (EI): m/z calcd for C₁₅H₁₄N₃O³⁵Cl: 287.0825; found: 287.0828. Compound 2e: yellow solid; mp 110–112 °C. ¹H NMR (400 MHz, DMSO-d ₆): δ = 3.87 (s, 3 H), 7.19–7.25 (m, 2 H), 7.40–7.44 (m, 1 H), 7.46–7.2 (m, 2 H), 7.76–7.80 (m, 3 H), 7.81–7.86 (m, 2 H), 7.93 (s, 1 H), 8.19–8.25 (m, 1 H). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 55.6, 108.2, 115.1, 119.9, 124.4, 124.8, 127.6, 128.0, 129.0, 129.3, 132.8, 139.6, 140.8, 145.0, 159.4. MS (EI): m/z (%) = 301 (20), 273 (45), 259 (22), 258 (100), 231 (14), 230 (68), 228 (10). HRMS (EI): m/z calcd for C₁₉H₁₅N₃O: 301.1215; found: 301.1219. Compound 2f: white solid; mp 116–119 °C. ¹H NMR (500 MHz, DMSO-d ₆): δ = 1.36 (t, J = 7.0 Hz, 3 H), 4.06 (s, 3 H), 4.11 (q, J = 7.0 Hz, 2 H), 6.96 (d, J = 1.5 Hz, 1 H), 7.14–7.17 (m, 2 H), 7.35 (d, J = 1.5 Hz, 1 H), 7.67–7.70 (m, 2 H). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 15.0, 57.2, 64.1, 102.9, 106.1, 115.9, 125.3, 129.1, 134.6, 134.9, 136.8, 151.8, 159.4. MS (EI): m/z (%) = 305 (39), 304 (21), 303 (82), 248 (53), 247 (49), 246 (100), 240 (58), 232 (37), 218 (37), 212 (87), 211 (12), 204 (51), 203 (26), 188 (20). HRMS (EI): m/z calcd for C₁₅H₁₄N₃O₂ ³⁵Cl: 303.0775; found: 303.0769. Compound 2g: orange solid; mp 123–126 °C. ¹H NMR (500 MHz, DMSO-d ₆): δ = 2.41 (s, 3 H), 7.36-7.41 (m, 1 H), 7.44–7.47 (m, 2 H), 7.70–7.73 (m, 3 H), 8.20–8.23 (m, 1 H). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 21.1, 97.4 (d, J _CF = 29 Hz), 114.8 (d, J _CF = 27 Hz), 122.0 (d, J _CF = 7 Hz), 123.1, 130.9, 132.7 (d, J _CF = 14 Hz), 134.1, 139.1, 143.1, 162.6 (d, J _CF = 244 Hz). MS (EI): m/z (%) = 227 (48), 199 (50), 198 (100), 184 (25). HRMS (EI): m/z calcd for C₁₃H₁₀N₃F: 227.0859; found: 227.0859. Compound 2h: orange solid; mp 109–111 °C. ¹H NMR (400 MHz, CDCl₃): δ = 2.52 (s, 3 H), 7.37–7.42 (m, 3 H), 7.43–7.50 (m, 2 H), 7.61–7.64 (m, 2 H), 7.65–7.69 (m, 3 H), 7.82–7.84 (m, 1 H), 8.15–8.19 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 21.4, 108.5, 120.5, 123.2, 124.9, 127.9, 128.2, 129.1, 130.6, 133.3, 134.7, 139.1, 140.8, 142.1, 146.0. MS (EI): m/z (%) = 285 (21), 258 (21), 257 (100), 256 (64), 140 (16), 139 (17). HRMS (EI): m/z calcd for C₁₉H₁₅N₃: 285.1266; found: 285.1266. Compound 2i: white solid, mp 155–158 °C. ¹H NMR (500 MHz, DMSO-d ₆): δ = 7.58–7.62 (m, 1 H), 8.02–8.04 (m, 2 H), 8.24–8.29 (m, 1 H), 8.30–8.33 (m, 1 H), 8.84–8.87 (m, 2 H). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 111.9, 116.3, 121.9, 126.5, 132.3, 135.0, 143.1, 145.3, 152.1. MS (EI): m/z (%) = 232 (31), 230 (68), 204 (46), 203 (20), 202 (91), 167 (48), 140 (53). HRMS (EI): m/z calcd for C₁₁H₇N₄ ³⁵Cl: 230.0359; found: 230.0359. Compound 2j: orange oil. ¹H NMR (500 MHz, CDCl₃): δ = 2.13 (s, 3 H), 7.35–7.44 (m, 4 H), 7.46–7.54 (m, 2 H), 8.08 (d, J = 8.8 Hz, 1 H). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 17.7, 109.9, 121.0, 125.4, 126.8, 127.1, 130.3, 131.8, 134.5, 134.6, 134.7, 135.3, 144.2. MS (EI): m/z (%) = 245 (20), 243 (43), 217 (19), 216 (36), 215 (40), 214 (74), 200 (21), 180 (100). HRMS (EI): m/z calcd for C₁₃H₁₀N₃ ³⁵Cl: 243.0563; found: 243.0562. Compound 2k: white solid; mp 200–202 °C. ¹H NMR (400 MHz, CDCl₃): δ = 7.19–7.25 (m, 1 H), 7.34–7.37 (m, 1 H), 7.57–7.62 (m, 2 H), 7.68–7.72 (m, 2 H), 8.09–8.13 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 96.3 (d, J _CF = 29 Hz), 114.6 (d, J _CF = 26 Hz), 122.1 (d, J _CF = 11 Hz), 124.0, 130.4, 132.7 (d, J _CF = 14 Hz), 134.9, 135.3, 143.5, 163.1 (d, J _CF = 248 Hz). MS (EI): m/z (%) = 247 (24), 219 (47), 185 (15), 184 (100), 158 (13), 157 (11). HRMS (EI): m/z calcd for C₁₂H₇N₃ ³⁵ClF: 247.0313; found: 247.0322. Compound 2l: white solid; mp 224–226 °C. IR (film; CH₂Cl₂): ν_max = 2226 (CN) cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.47 (dd, J = 8.8, 2.8 Hz, 1 H), 7.96 (d, J = 2.8 Hz, 1 H), 7.93–7.99 (m, 4 H), 8.11 (d, J= 8.8 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 110.2, 112.7, 117.9, 121.9, 122.7, 125.0, 126.4, 132.5, 134.2, 136.0, 140.1. MS (EI): m/z (%) = 256 (17), 254 (49), 228 (44), 226 (99), 192 (23), 191 (100), 102 (56). HRMS (EI): m/z calcd for C₁₃H₇N₄ ³⁵Cl: 254.0359; found: 254.0358. Compound 2m: white solid, mp 170–172 °C. ¹H NMR (400 MHz, CDCl₃): δ = 3.91 (s, 3 H), 7.09–7.13 (m, 2 H), 7.37 (dd, J = 8.8, 1.6 Hz, 1 H), 7.60–7.64 (m, 2 H), 7.65 (d, J = 1.6 Hz, 1 H), 8.04 (d, J = 8,8 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 55.8, 110.2, 115.2, 121.2, 124.7, 125.5, 129.6, 133.4, 134.6, 144.9, 160.2. MS (EI): m/z (%) = 261 (13), 259 (39), 218 (34), 216 (100), 196 (90), 190 (21), 189 (10), 188 (66), 181 (20), 153 (35). HRMS (EI): m/z calcd for C₁₃H₁₀N₃O³⁵Cl: 259.0512; found: 259.0513. Compound 2n: white solid, mp 135–138 °C. ¹H NMR (400 MHz, CDCl₃): δ = 7.36 (d, J = 2 Hz, 1 H), 7.41 (dd, J = 8.8, 2.4 Hz, 1 H), 7.45–7.49 (m, 1 H), 7.54–7.57 (m, 1 H), 7.86 (d, J = 2.4 Hz, 1 H), 8.08 (d, J = 8.8 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 110.3, 121.4, 121.6, 125.8, 129.2, 130.2, 134.1, 134.3, 135.2, 137.5, 144.4 (one signal not visible). MS (EI): m/z (%) = 343 (25), 340 (13), 314 (16), 279 (21), 277 (16), 236 (65), 234 (100), 199 (20), 198 (18), 164 (26). HRMS (EI): m/z calcd for C₁₂H₆N₃ ³⁵Cl₂ ⁷⁹Br: 340.9122; found: 340.9127. Compound 2o: colorless oil. ¹H NMR (400 MHz, CDCl₃): δ = 1.93 (s, 6 H), 6.84–6.87 (m, 1 H), 7.17–7.22 (m, 1 H), 7.25–7.27 (m, 2 H), 7.37–7.41 (m, 1 H), 8.10–8.14 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 17.6, 95.5 (d, J _CF = 27 Hz), 114.2 (d, J _CF = 27 Hz), 121.8 (d, J _CF = 11 Hz), 128.9, 130.6, 133.9, 134.4 (d, J _CF = 14 Hz), 136.6, 142.5, 163.0 (d, J _CF = 248 Hz). MS (EI): m/z (%) = 241 (68), 213 (36), 212 (100), 211 (17), 199 (24), 198 (83). HRMS (EI): m/z calcd for C₁₄H₁₂N₃F: 241.1015; found: 241.1013. Compound 2p: white solid; mp 134–137 °C. ¹H NMR (400 MHz, CDCl₃): δ = 3.88 (s, 6 H), 6.59 (t, J = 2.0 Hz, 1 H), 6.88–6.90 (m, 2 H), 7.49 (dd, J = 8.8, 1.6 Hz, 1 H), 7.77 (d, J = 1.6 Hz, 1 H), 8.05 (d, J = 8.8 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 55.9, 100.8, 101.5, 110.6, 121.3, 125.8, 133.0, 134.9, 138.2, 145.2, 161.8. MS (EI): m/z (%) = 291 (32), 290 (16), 289 (83), 261 (33), 246 (28), 227 (22), 226 (100), 218 (49), 203 (44), 183 (18). HRMS (EI): m/z calcd for C₁₄H₁₂N₃O₂ ³⁵Cl: 289.0618; found: 289.0623. Compound 2q: white solid; mp 142–144 °C. ¹H NMR (400 MHz, CDCl₃): δ = 2.48 (s, 3 H), 7.39–7.44 (m, 2 H), 7.52 (dd, J = 8.8, 1.6 Hz, 1 H), 7.58–7.63 (m, 2 H), 7.88 (d, J = 1.6 Hz, 1 H), 8.00 (d, J = 8.8 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 21.3, 113.5, 121.5, 122.6, 123.1, 128.1, 130.6, 133.6, 134.2, 139.4, 145.4. MS (EI): m/z (%) = 289 (24), 287 (24), 261 (21), 260 (31), 259 (22), 258 (29), 181 (26), 180 (100), 179 (23), 178 (11). HRMS (EI): m/z calcd for C₁₃H₁₀N₃ ⁷⁹Br: 287.0058; found: 287.0061. Compound 4: white solid; mp 122–124 °C. IR (film; CH₂Cl₂): ν_max = 1531 (NO₂) cm^–1. ¹H NMR (500 MHz, CDCl₃): δ = 2.50 (s, 3 H), 4.00 (s, 3 H), 7.11 (s, 1 H), 7.44–7.47 (m, 2 H), 7.57–7.60 (m, 2 H), 8.56 (s, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 21.3, 57.0, 92.2, 118.0, 123.2, 130.7, 133.6, 134.4, 138.9, 139.5, 139.8, 153.3. MS (EI): m/z (%) = 284 (100), 241 (41), 211 (21), 210 (90), 196 (11), 183 (33), 181 (28), 180 (80). HRMS (EI): m/z calcd for C₁₄H₁₂N₄O₃: 284.0909; found: 284.0918. Compound 5: colorless oil. ¹H NMR (400 MHz, CDCl₃): δ = 1.93 (s, 6 H), 7.08 (d, J = 9.2 Hz, 1 H), 7.29–7.31 (m, 2 H), 7.43–7.47 (m, 1 H), 8.95 (d, J = 6.4 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 17.6, 98.2 (d, J _CF = 26 Hz), 119.8, 129.2, 131.2, 133.1, 135.6 (d, J _CF = 12 Hz), 136.4, 139.4, 140.2, 155.5. MS (EI): m/z (%) = 286 (86), 241 (15), 228 (13), 213 (34), 212 (100), 211 (70), 210 (38), 209 (21), 185 (21). HRMS (EI): m/z calcd for C₁₄H₁₁N₄O₂F: 286.0866; found: 286.0869. Compound 6: brown oil. IR (film; CH₂Cl₂): ν_max = 2094 (>=N=N), 1713 (C=O stretching) cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 0.89–0.94 (m, 3 H), 1.28–1.38 (m, 2 H), 1.57–1.66 (m, 2 H), 3.62–3.66 (m, 2 H), 6.21 (d, J = 1.6 Hz, 1 H), 6.30 (dd, J = 9.6, 1.6 Hz, 1 H), 6.99–7.02 (m, 2 H), 7.05 (d, J = 9.6 Hz, 1 H), 7.30–7.33 (m, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 13.9, 20.3, 29.3, 54.6, 109.5, 113.6, 124.8, 125.0, 129.0, 130.3, 130.7, 144.7, 150.0, 183.1. Compound 7: orange solid; mp 199–200 °C. IR (film; CH₂Cl₂): ν_max = 3253 (NH), 1693 (C=O stretching) cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 2.22 (s, 6 H), 5.45 (s, 1 H), 7.14–7.23 (m, 3 H), 7.28 (s, 1 H), 7.66–7.69 (m, 1 H), 8.41–8.44 (m, 1 H), 8.96–8.98 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 18.1, 102.4, 128.4, 128.6, 129.0, 130.9, 133.3, 134.4, 135.8, 147.0, 147.2, 153.3, 180.4, 182.2. MS: m/z = 279.2 [M + H]. Anal. Calcd (%) for C₁₇H₁₄N₂O₂: C, 73.37; H, 5.07; N, 10.06. Found: C, 73.22; H, 5.26; N, 9.95.

15a Sundberg RJ, Baxter EW, Pitts WJ, Ahmed-Schofield R, Nishiguchi T. J. Org. Chem. 1988; 53: 5097
15b Adam W, Hadjiarapoglou L, Mielke K, Treiber A. Tetrahedron Lett. 1994; 5625

16 Mukhopadhyay C, Tapaswi PK, Butcher RJ. Org. Biomol. Chem. 2010; 8: 4720

Supplementary Material

Supporting Information